| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 315.82M | 310.71M | 306.37M | 167.72M | 145.14M | 127.75M |
| Gross Profit | 128.39M | 136.43M | 147.40M | 100.17M | 93.48M | 81.41M |
| EBITDA | 62.56M | 60.03M | 77.25M | 55.71M | 61.13M | 30.57M |
| Net Income | 16.47M | 19.19M | 35.69M | 34.71M | 39.68M | 22.34M |
Balance Sheet | ||||||
| Total Assets | 605.21M | 508.35M | 519.11M | 479.99M | 232.13M | 284.92M |
| Cash, Cash Equivalents and Short-Term Investments | 151.93M | 33.19M | 86.77M | 160.45M | 24.30M | 10.54M |
| Total Debt | 118.00M | 105.49M | 98.77M | 100.42M | 51.79M | 87.03M |
| Total Liabilities | 503.26M | 411.03M | 397.95M | 368.27M | 148.88M | 251.62M |
| Stockholders Equity | 97.75M | 93.21M | 121.16M | 111.71M | 83.26M | 33.30M |
Cash Flow | ||||||
| Free Cash Flow | 7.11M | 5.62M | 37.78M | 81.00M | 11.76M | 43.74M |
| Operating Cash Flow | 16.15M | 24.39M | 53.99M | 93.70M | 22.57M | 54.98M |
| Investing Cash Flow | 14.16M | -43.90M | -16.33M | -57.05M | -4.68M | -72.02M |
| Financing Cash Flow | -45.16M | -34.08M | -28.81M | 17.06M | -58.39M | -10.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | £843.90M | 14.18 | 64.69% | 5.54% | 1.58% | -6.06% | |
77 Outperform | £156.06M | 6.83 | 104.64% | 7.02% | 1.57% | 1.80% | |
68 Neutral | £448.87M | 55.26 | 6.99% | ― | 25.86% | 225.77% | |
64 Neutral | £354.25M | 8.32 | 17.25% | 20.30% | 1.58% | -57.55% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £738.21M | 413.34 | 0.15% | ― | 4.39% | -33.33% | |
52 Neutral | £47.00M | -8.69 | -32.65% | ― | -5.08% | -97.88% |